Inventor · disambiguated record
Mark T. Marino
Also filed as: MARINO MARK · MARINO MARK T
8 granted patents·8 pending applications·132 citations·filing 2010–2022
84Inventor score
Files withMANNKIND CORP10COSTELLO DONALD2SMUTNEY CHAD C2ELLODI PHARMACEUTICALS L P1PLUS THERAPEUTICS INC1
Top patents by PatentIndex Score
16 records- 0197US8485180B2Dry powder drug delivery systemSMUTNEY CHAD C·Filed 2010·Granted Jul 16, 2013·113 cites·21 claims
- 0291US9662461B2Dry powder drug delivery system and methodsMANNKIND CORP·Filed 2016·Granted May 30, 2017·10 cites·20 claims
- 0381US11304992B2Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2019·Granted Apr 19, 2022·1 cites·6 claims
- 0481US9393372B2Dry powder drug delivery systemMANNKIND CORP·Filed 2013·Granted Jul 19, 2016·4 cites·20 claims
- 0573US8921311B2Method for treating hyperglycemiaCOSTELLO DONALD·Filed 2011·Granted Dec 30, 2014·1 cites·28 claims
- 0669US9358352B2Dry powder drug delivery system and methodsSMUTNEY CHAD C·Filed 2011·Granted Jun 7, 2016·1 cites·21 claims
- 0767US9078866B2Method for treating hyperglycemia with GLP-1COSTELLO DONALD·Filed 2010·Granted Jul 14, 2015·2 cites·12 claims
- 0863US2015080298A1Method for treating hyperglycemiaMANNKIND CORP·Filed 2014·Application pending·0 cites
- 0962US2021244897A1Dry powder drug delivery systemMANNKIND CORP·Filed 2021·Application pending·0 cites
- 1059US2023293436A1Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2022·Application pending·0 cites
- 1156US2019262557A1Dry powder drug delivery systemMANNKIND CORP·Filed 2019·Application pending·0 cites
- 1255US10342938B2Dry powder drug delivery systemMANNKIND CORP·Filed 2016·Granted Jul 9, 2019·0 cites·19 claims
- 1355US2017304404A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2017·Application pending·0 cites
- 1453US2022347189A1Methods of treating eosinophilic esophagitis and reducing candidiasisELLODI PHARMACEUTICALS L P·Filed 2020·Application pending·0 cites
- 1550US2015283213A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2015·Application pending·0 cites
- 1646US2020390702A1Liposomal taxanes for treatment of sclcPLUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →